What's Happening?
Nuclera has introduced a nanodisc panel designed to streamline the production of G-protein coupled receptors (GPCRs). The panel supports screening and scale-up of GPCRs, allowing researchers to identify
optimal membrane environments and increase production of challenging therapeutic targets. The nanodisc panel includes a GPCR screen kit and scale-up reagents, enabling rapid expression of active GPCRs. This approach minimizes variability associated with traditional membrane protein production methods, providing a fast-track route to purified, active GPCRs.
Why It's Important?
The launch of Nuclera's nanodisc panel addresses a critical bottleneck in pharmacology and drug discovery. By facilitating the rapid production of functional GPCRs, the panel enhances the efficiency of drug development processes. GPCRs are significant targets for FDA-approved drugs, and improving their production could lead to advancements in therapeutic interventions. The ability to produce active proteins quickly and cost-effectively could accelerate research and development in the pharmaceutical industry.
